Disclosure of pharmacokinetic drug results to understand nonadherence: results from a qualitative study

OBJECTIVES: In VOICE, a phase IIB trial of daily oral and vaginal tenofovir for HIV prevention, ≥50% of women receiving active products had undetectable tenofovir in all plasma samples tested. MTN-003D, an ancillary study using in-depth interviews (IDIs) and focus group discussions (FGDs), together...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: VAN DER STRATEN, Ariane, MONTGOMERY, Elizabeth T., MUSARA, Petina, ETIMA, Juliane, NAIDOO, Sarita, LABORDE, Nicole, HARTMANN, Miriam, LEVY, Lisa, BENNIE, Thola, CHENG, Helen, PIPER, Jeanna, GROSSMAN, Cynthia I., MARRAZZO, Jeanne, MENSCH, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638164/
https://ncbi.nlm.nih.gov/pubmed/26544581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000801
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados